Form 8-K - Current report:
SEC Accession No. 0001641172-25-021882
Filing Date
2025-08-01
Accepted
2025-08-01 15:23:32
Documents
13
Period of Report
2025-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41028
2 EX-10.1 ex10-1.htm EX-10.1 57786
  Complete submission text file 0001641172-25-021882.txt   276143

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rgbp-20250728.xsd EX-101.SCH 3041
4 XBRL LABEL FILE rgbp-20250728_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE rgbp-20250728_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3460
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 251175919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)